BioSpace News Archive

Cambrex announced the acquisition of Q1 Scientific – a leading provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located in Waterford, Ireland.

OrthoTrophix, Inc. announced that the Company will present the latest clinical data and registration plan of TPX-100 in knee osteoarthritis patients at BIO 2022.

Design Therapeutics, Inc. announced that João Siffert, M.D., president and chief executive officer, will present at the 2022 Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 8:30 a.m. ET in New York City.

BIOLASE, Inc., the global leader in dental lasers, announced that due to the growing adoption of its market leading laser technology, BIOLASE has taken the innovative step of creating a multi-dimensional integration team to support the optimal use of BIOLASE dental lasers in practices across North America.

AmerisourceBergen Corporation reiterated its previously provided guidance for fiscal year 2022 and announced that its Board of Directors has authorized a new share repurchase program.

KalVista Pharmaceuticals, Inc. announced it will be presenting at the 13th Annual Jefferies Global Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. ET.

Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker.

Lannett Company, Inc. (NYSE: LCI) today provided an update on its ongoing pivotal clinical trial of biosimilar insulin glargine.

Amryt announces that copies of the Company’s annual report for the year ended December 31, 2021 have been sent to Shareholders along with the Notice of Annual General Meeting.

Zynerba Pharmaceuticals, Inc. is presenting an oral podium presentation and a poster presentation at the American Society of Clinical Psychopharmacology Annual Meeting, being held May 31 – June 3, 2022, in Scottsdale, Ariz.